Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy

Figure 3

Comparative analysis of the 5-year DMFS of patients who received IMRT alone and patients who received combined chemoradiotherapy.